July 24, 2014 4:28 PM ET

Biotechnology

Company Overview of Critical Therapeutics Inc.

Company Overview

As of October 31, 2008, Critical Therapeutics Inc. was acquired by Cornerstone BioPharma Holdings, Inc., in a reverse merger transaction. Critical Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products to treat respiratory, inflammatory, and critical care diseases linked to body’s inflammatory response. It markets ZYFLO CR, a formulation of zileuton for the prevention and treatment of asthma in adults and children. The company also holds exclusive worldwide rights to ZYFLO CR; ZYFLO, an immediate-release tablet formulation of zileuton; and other formulations of zileuton for multiple diseases and conditions. In addition, Critical Therapeutics is de...

60 Westview Street

Lexington, MA 02421

United States

Founded in 2000

42 Employees

Phone:

781-402-5700

Fax:

617-354-9318

Key Executives for Critical Therapeutics Inc.

Critical Therapeutics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Precision Genome Engineering, Inc. United States
EMD Biosciences, Inc. United States
Riverside Therapeutics Inc. United States
CellExSys, Inc. United States
Antria, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Critical Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.